Adrian Oblak
Postdoctoral Fellow
Boston University School of Medicine
Dept of Anatomy & Neurobiology

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Lin PB, Wang PK, Pang CY, Hu WF, Tsai AP, Oblak AL, Liew HK. Moderate Ethanol Pre-treatment Mitigates ICH-Induced Injury via ER Stress Modulation in Rats. Front Mol Neurosci. 2021; 14:682775. PMID: 34248500; PMCID: PMC8267178; DOI: 10.3389/fnmol.2021.682775;
  2. Tsai AP, Lin PB, Dong C, Moutinho M, Casali BT, Liu Y, Lamb BT, Landreth GE, Oblak AL, Nho K. INPP5D expression is associated with risk for Alzheimer's disease and induced by plaque-associated microglia. Neurobiol Dis. 2021 Jun; 153:105303. PMID: 33631273; PMCID: PMC8082515; DOI: 10.1016/j.nbd.2021.105303;
  3. Oblak AL, Forner S, Territo PR, Sasner M, Carter GW, Howell GR, Sukoff-Rizzo SJ, Logsdon BA, Mangravite LM, Mortazavi A, Baglietto-Vargas D, Green KN, MacGregor GR, Wood MA, Tenner AJ, LaFerla FM, Lamb BT. Model organism development and evaluation for late-onset Alzheimer's disease: MODEL-AD. Alzheimers Dement (N Y). 2020; 6(1):e12110. PMID: 33283040; PMCID: PMC7683958; DOI: 10.1002/trc2.12110;
  4. Preuss C, Pandey R, Piazza E, Fine A, Uyar A, Perumal T, Garceau D, Kotredes KP, Williams H, Mangravite LM, Lamb BT, Oblak AL, Howell GR, Sasner M, Logsdon BA, Carter GW. A novel systems biology approach to evaluate mouse models of late-onset Alzheimer's disease. Mol Neurodegener. 2020 11 10; 15(1):67. PMID: 33172468; PMCID: PMC7656729; DOI: 10.1186/s13024-020-00412-5;
  5. Jadhav VS, Lin PBC, Pennington T, Di Prisco GV, Jannu AJ, Xu G, Moutinho M, Zhang J, Atwood BK, Puntambekar SS, Bissel SJ, Oblak AL, Landreth GE, Lamb BT. Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice. Mol Neurodegener. 2020 10 28; 15(1):62. PMID: 33115519; PMCID: PMC7594478; DOI: 10.1186/s13024-020-00409-0;
  6. Reilly AM, Tsai AP, Lin PB, Ericsson AC, Oblak AL, Ren H. Metabolic Defects Caused by High-Fat Diet Modify Disease Risk through Inflammatory and Amyloidogenic Pathways in a Mouse Model of Alzheimer's Disease. Nutrients. 2020 Sep 29; 12(10). PMID: 33003412; PMCID: PMC7600118; DOI: 10.3390/nu12102977;
  7. Sukoff Rizzo SJ, Masters A, Onos KD, Quinney S, Sasner M, Oblak A, Lamb BT, Territo PR. Improving preclinical to clinical translation in Alzheimer's disease research. Alzheimers Dement (N Y). 2020; 6(1):e12038. PMID: 32548237; PMCID: PMC7293992; DOI: 10.1002/trc2.12038;
  8. Xu C, Apostolova LG, Oblak AL, Gao S. Association of Hypercholesterolemia with Alzheimer's Disease Pathology and Cerebral Amyloid Angiopathy. J Alzheimers Dis. 2020; 73(4):1305-1311. PMID: 31929164; PMCID: PMC7489304; DOI: 10.3233/JAD-191023;
  9. Gondim DD, Oblak A, Murrell JR, Richardson R, Epperson F, Ross OA, Ghetti B. Diffuse Lewy Body Disease and Alzheimer Disease: Neuropathologic Phenotype Associated With the PSEN1 p.A396T Mutation. J Neuropathol Exp Neurol. 2019 07 01; 78(7):585-594. PMID: 31165862; PMCID: PMC6581554; DOI: 10.1093/jnen/nlz039;
  10. Orczykowski ME, Calderazzo SM, Shobin E, Pessina MA, Oblak AL, Finklestein SP, Kramer BC, Mortazavi F, Rosene DL, Moore TL. Cell based therapy reduces secondary damage and increases extent of microglial activation following cortical injury. Brain Res. 2019 08 15; 1717:147-159.View Related Profiles. PMID: 30998931; PMCID: PMC6530569; DOI: 10.1016/j.brainres.2019.04.015;
Showing 10 of 32 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 32 publications over 12 distinct years, with a maximum of 6 publications in 2020


Contact for Mentoring:

72 E. Concord St Housman (R)
Boston MA 02118
Google Map

Oblak's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department